MicroCME: Is SMART Therapy a Thing for the Pediatric Asthmatic?
Price: FREE to members; $20 non-members
Length: 20 minutes
This microlearning, presented by Dr. Leonard Bacharier, discusses whether SMART Therapy is appropriate for the Pediatric Asthmatic.
Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
Practicing allergists
Allied health professionals
Primary Care Providers
Fellows-in-Training
Learning Objectives
By participating in this course, learners should be able to:
- Relate increased knowledge of how MART and biologics can best be utilized in the pediatric population, which has less data on their use.
Planners and Reviewers
Brianne Nicole Navetta-Modrov, MD, FACAAI
Nothing to Disclose
Deepa Patadia, MD
Nothing to Disclose
Deepti Vellaichamy Manian, MD
Nothing to Disclose
Farah Nawaz Khan, MD, FACAAI
Doximity: stocks/stock options
Joel S. Klein, MD, FACAAI
Nothing to Disclose
Karen M. Anstey, MD
Nothing to Disclose
Tammy Peng, MD
Nothing to Disclose
Mary Brandt Hudelson, MD, FACAAI
Nothing to Disclose
Mechelle Miller Vazquez, MD
Nothing to Disclose
Available Credit
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Attendance